Matoma already knew that the test had passed, and he revealed the news to his boss, Cohensek Capital, who bought a large amount of US$700 million in pharmaceutical stocks. This is the trend of Yilan's stock price. At this stage.
Sec Capital began to take a look at its heavy positions, and this position was the day when the test results were announced, and the stock price soared by 40%. Matoma has done something. But this is just the beginning.
For a new drug, the most important thing is the Phase III trial. The results of the third phase will be announced in 45 days. According to the position information disclosed by the US Securities Regulatory Commission, SEC Capital at this time.
Has been bought into Yilan's largest shareholder. Wall Street generally believes that as long as Cohen's brain is not broken, then he is so heavy, he must know that the results of the third phase test are positive, and Cohen is indeed confident.
But he couldn't think of it, Matoma's optimistic estimate is not reliable. On July 17, 2008, two weeks before the results of the third phase were announced, Professor Ji delivered 24 pages of experimental data.